Tango Therapeutics, Inc. - Common Stock (TNGX)

Historical Holders from Q3 2021 to Q3 2025

Symbol
TNGX on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
134,608,103
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
139,978,941
Holdings value
$1,175,803,271
% of all portfolios
0.007%
Number of holders
141
Number of buys
84
Number of sells
-45
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Tango Therapeutics, Inc. - Common Stock (TNGX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Farallon Capital Partners, L.P. 9.7% +16.2% $90,358,800 +$13,440,000 10,757,000 +17.5% Dapice Joshua J. 30 Sep 2025
EcoR1 Capital, LLC 9.9% $15,520,875 10,630,736 EcoR1 Capital, LLC 31 Dec 2024
TCG Crossover GP II, LLC 6.3% $71,704,046 8,536,196 TCG Crossover GP II, LLC 30 Sep 2025
Third Rock Ventures IV, L.P. 5.85% -16% $62,760,355 -$11,955,000 7,874,574 -16% Third Rock Ventures IV, L.P. 19 Nov 2025
Woodline Partners LP 5.6% $35,757,343 6,029,906 Woodline Partners LP 30 Jun 2025
Invus Global Management, LLC 5.3% $40,593,997 5,883,188 Raymond Debbane 19 Sep 2025
BlackRock, Inc. 5% $27,939,994 5,457,030 BlackRock, Inc. 30 Jun 2025
Adage Capital Management, L.P. 2.26% -63.8% $21,092,400 -$28,512,532 2,511,000 -57.5% Adage Capital Management, L.P. 30 Sep 2025
FMR LLC 0% $19,552 13,392 FMR LLC 29 Nov 2024

Institutional Holders of Tango Therapeutics, Inc. - Common Stock (TNGX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 139,978,941 $1,175,803,271 +$109,407,056 $8.4 141
2025 Q2 127,196,008 $651,244,300 +$113,427,538 $5.12 114
2025 Q1 107,228,944 $146,966,295 -$1,500,604 $1.37 119
2024 Q4 106,381,203 $328,721,243 -$120,601,739 $3.09 134
2024 Q3 101,459,260 $781,203,088 -$3,564,439 $7.7 119
2024 Q2 98,595,824 $845,901,469 +$2,628,498 $8.58 116
2024 Q1 98,377,909 $781,109,580 +$30,778,538 $7.94 124
2023 Q4 93,643,916 $927,104,831 +$41,143,001 $9.9 118
2023 Q3 88,799,639 $999,861,944 +$236,872,193 $11.26 99
2023 Q2 68,320,832 $226,845,382 -$7,737,842 $3.32 89
2023 Q1 69,836,747 $275,851,159 +$1,770,332 $3.95 91
2022 Q4 68,766,073 $498,554,976 +$12,927,727 $7.25 83
2022 Q3 68,157,717 $246,729,459 -$12,119,590 $3.62 86
2022 Q2 70,452,006 $319,137,805 -$11,072,751 $4.53 76
2022 Q1 69,679,958 $528,174,476 +$13,385,662 $7.58 70
2021 Q4 67,775,150 $740,996,532 +$24,899,642 $10.94 57
2021 Q3 65,465,348 $844,863,000 +$844,863,000 $12.93 45